The cytotoxic effects of lipidic formulated gold porphyrin nanoparticles for the treatment of neuroblastoma.

OBJECTIVE Nanotechnology has been identified as a promising platform in the improvement of the design and development of drug delivery systems. In the present study we investigated the potential of lipidic nanoparticles consisting of gold porphyrin for the treatment of neuroblastoma. MATERIALS AND METHODS To characterize the size of the lipidic gold porphyrin nanoparticles, we used transmission electron microscopy (TEM). The in vitro cytotoxic effect on neuroblastoma activity was examined using XTT cell proliferation assay, then IC50 values were calculated. In vivo safety and toxicity were studied using intraperitoneal injection of gold porphyrin nanoparticles into normal animals. Finally, tumor size measurement and animal survival were studied to investigate the therapeutic effect of lipidic gold porphyrin nanoparticles on neuroblastoma growth. RESULTS We found that incorporation of gold porphyrin into lipidic nanoparticles resulted in a 16-fold increase in size. Subsequent in vitro and in vivo cytotoxicity studies further showed that the lipidic gold porphyrin nanoparticles could decrease systemic toxicity, as well as inhibiting tumor growth following administration into the neuroblastoma bearing mice. CONCLUSION The delivery of lipidic gold porphyrin nanoparticles by incorporation with lipidic formulation is feasible approach to treat neuroblastoma. We await further studies to evaluate tumor killing kinetics.

[1]  L. Rybak,et al.  Cisplatin ototoxicity and protection: clinical and experimental studies. , 2009, The Tohoku journal of experimental medicine.

[2]  B. Wong,et al.  Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer , 2009, Cancer.

[3]  T. Niidome,et al.  The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[4]  P. Nathan,et al.  Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. , 2009, Journal of the National Cancer Institute.

[5]  C. Che,et al.  Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition , 2009, British Journal of Cancer.

[6]  C. Che,et al.  The anti-cancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligands , 2009 .

[7]  A. Casini,et al.  Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs , 2009 .

[8]  P. Tam,et al.  Gold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinoma in vitro and in vivo , 2009, International journal of cancer.

[9]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[10]  Qing‐Yu He,et al.  Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species , 2005 .

[11]  J. Oh,et al.  Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles , 2005, Pharmaceutical Research.

[12]  Y. Sohn,et al.  Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates. , 2005, Journal of inorganic biochemistry.

[13]  Tetsuro Tanaka,et al.  Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). , 2004, International journal of pharmaceutics.

[14]  Hongzhe Sun,et al.  Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. , 2003, Chemical communications.

[15]  Lin Chen,et al.  CpG-oligodeoxynucleotide rejection of a neuroblastoma in A/J mice does not induce a paraneoplastic disease , 2002, Neuroscience Letters.

[16]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[17]  W. Middlesworth,et al.  All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor. , 2001, Journal of pediatric surgery.

[18]  K K Matthay,et al.  Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .

[19]  C. Shaw.  Gold-Based Therapeutic Agents , 1999 .

[20]  J. Pezzuto,et al.  Betulinic acid induces apoptosis in human neuroblastoma cell lines. , 1997, European journal of cancer.

[21]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[22]  P. Anderson,et al.  Retroperitoneal inoculation of murine neuroblastoma results in a reliable model for evaluation of the antitumor immune response. , 1994, Journal of pediatric surgery.

[23]  G. Zientara,et al.  Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. , 1989, Cancer research.

[24]  J. Kopeček,et al.  Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. , 1987, Journal of biomedical materials research.

[25]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[26]  M. Grunze,et al.  Lateral segregation of membrane lipids and formation of stable rod-shaped membrane projections in erythrocytes treated with long-chain alcohols. , 1982, Biochimica et biophysica acta.

[27]  R. Mumper,et al.  Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors , 2008, AAPS PharmSciTech.

[28]  Xiaogang Pan,et al.  Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. , 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[29]  H. Maeda,et al.  Tumoritropic and lymphotropic principles of macromolecular drugs. , 1989, Critical reviews in therapeutic drug carrier systems.